Faculty Perspectives: Comprehensive Biomarker Testing in NSCLC: Opportunities to Advance Precision Medicine

Supported through funding by

Introduction

For this supplement, expert faculty provided detailed perspectives based on their extensive experience in the management of non–small-cell lung cancer (NSCLC), focusing on the incorporation and considerations for biomarker testing in precision medicine.